Lv1
60 积分 2024-07-10 加入
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting
1天前
已完结
Biology drives the discovery of bispecific antibodies as innovative therapeutics
1天前
已完结
Bispecific dendritic-T cell engager potentiates anti-tumor immunity
24天前
已完结
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
3个月前
已完结
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
3个月前
已完结
Ponatinib delays the growth of solid tumours by remodelling immunosuppressive tumour microenvironment through the inhibition of induced PD-L1 expression
4个月前
已完结
皖公网安备34019202002308
